AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇬🇭

Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate in Ghana

12 products registered with FDA Ghana 8 active, 4 expired

Brand / ProductReg. No.HolderStatusExpires
ACRIPTEGA TABLETS (Each film-coated tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg)UNKNOWN-972cdd0cactive1 Jul 2030
ACRIPTEGA TABLETS (Each film-coated tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg)UNKNOWN-7ce6ebf3active1 Jul 2030
VIROPILUNKNOWN-285d833aactive1 Oct 2029
VIROPILUNKNOWN-b6519a0aactive1 Oct 2029
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 500mg/300mg/300mg )UNKNOWN-a2ba8fefexpired1 Sept 2026
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 500mg/300mg/300mg )UNKNOWN-52d9e1cbactive1 Sept 2026
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg)UNKNOWN-fe8fe8f6active1 Sept 2026
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 500mg/300mg/300mg )UNKNOWN-99336837active1 Sept 2026
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg)UNKNOWN-b15ebf74expired1 Sept 2026
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg)UNKNOWN-d03a4375active1 Sept 2026
Dolutegravir/Lamivudine/Tenofovir Disoproxil FumarateUNKNOWN-858bc7c9expired1 Aug 2026
Dolutegravir/Lamivudine/Tenofovir Disoproxil FumarateUNKNOWN-8451ca28expired1 Aug 2026

Dolutegravir/Lamivudine/Tenofovir Disoproxil FumarateFDA Ghana Registration Details

FDA Ghana (Ghana) has 12 registered products containing Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate, of which 8 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.

Track Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate — Ghana (FDA Ghana) | AfricaRegulatory